Insider trades
Belanoff Joseph K., CEO of Corcept Therapeutics CORT, has filed 0 purchases and 31 sales on the open market. Over the past 12 months that comes to a net sale of $10.4M. The latest trade was on 06/01.
Belanoff Joseph K.
CEO
- Company
- Corcept Therapeutics CORT
- First filing
- 23/02/15
- Trades
- 46 trades
- Buys / sales
- 0 / 31
- 12-month net buying
- −$10.4M
- Last trade
- 06/01
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 06/01 | 06/02 | 12,837 sh | $69.74 | $895,252.38 | −0.5% | |
| Open-market sale10b5-1 plan | 05/01 | 05/05 | 40,000 sh | $50.10 | $2,004,000 | −1.4% | |
| Open-market sale10b5-1 plan | 03/25 | 03/27 | 26,198 sh | $50.07 | $1,311,733.86 | −0.9% | |
| Open-market sale10b5-1 plan | 25/12/01 | 25/12/03 | 40,000 sh | $79.77 | $3,190,800 | −1.5% | |
CORT | Open-market sale10b5-1 plan | 25/11/03–25/11/05 | 25/11/05 | 40,000 sh4 trades | $74.58avg. | $2,983,230.82 | −1.4% |
CORT | Open-market sale10b5-1 plan | 25/10/01 | 25/10/03 | 40,000 sh3 trades | $85.08avg. | $3,403,143.02 | −1.4% |
CORT | Open-market sale10b5-1 plan | 25/09/02 | 25/09/04 | 40,000 sh2 trades | $70.53avg. | $2,821,143 | −1.4% |
CORT | Open-market sale10b5-1 plan | 25/08/01 | 25/08/05 | 40,000 sh3 trades | $68.53avg. | $2,741,298.18 | −1.4% |
| Open-market sale10b5-1 plan | 25/07/17 | 25/07/21 | 615 sh | $73.69 | $45,319.35 | −0.0% | |
CORT | Open-market sale10b5-1 plan | 25/06/02 | 25/06/04 | 40,000 sh8 trades | $82.86avg. | $3,314,243.37 | −1.4% |
CORT | Open-market sale10b5-1 plan | 25/05/02 | 25/05/05 | 40,000 sh2 trades | $72.90avg. | $2,915,864 | −1.3% |
CORT | Open-market sale10b5-1 plan | 25/03/31–25/04/01 | 25/04/02 | 35,452 sh2 trades | $94.92avg. | $3,365,009.94 | −1.2% |
| Open-market sale10b5-1 plan | 25/03/24 | 25/03/26 | 1,974 sh | $60.83 | $120,078.42 | −0.1% | |
| Open-market sale10b5-1 plan | 25/03/03 | 25/03/04 | 2,924 sh | $60.91 | $178,100.84 | −0.1% |